WuXi AppTec Inc. announced that it has entered into partnership with QIAGEN to provide an integrated single solution for molecular biomarker development. The laboratory will be located at WuXi AppTec's campus in Shanghai and will begin operating immediately.
Pursuant to deal, QIAGEN will provide a complete portfolio of instrumentation, training, and consumables and WuXi AppTec will provide laboratory facilities and staff to execute the services.
Under the terms of deal, WuXi AppTec will also work with QIAGEN to help develop biomarkers, assay panels, personalized healthcare diagnostics, and other products that QIAGEN intends to bring to market. WuXi AppTec and QIAGEN will also co-promote each other's services to their respective customers.
For comments and feedback: editorial@rttnews.com